Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Short-term Investments: 2020-2025

Historic Short-term Investments for Insight Molecular Diagnostics (IMDX) over the last 3 years, with Sep 2025 value amounting to $729,000.

  • Insight Molecular Diagnostics' Short-term Investments was N/A to $729,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $729,000, marking a year-over-year change of. This contributed to the annual value of $433,000 for FY2022, which is 52.10% down from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Short-term Investments is $729,000, which was up 65.31% from $441,000 recorded in Q3 2023.
  • In the past 5 years, Insight Molecular Diagnostics' Short-term Investments registered a high of $1.1 million during Q2 2021, and its lowest value of $419,000 during Q3 2022.
  • Over the past 2 years, Insight Molecular Diagnostics' median Short-term Investments value was $530,000 (recorded in 2023), while the average stood at $566,667.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Short-term Investments surged by 222.58% in 2021 and then tumbled by 54.60% in 2022.
  • Over the past 4 years, Insight Molecular Diagnostics' Short-term Investments (Quarterly) stood at $904,000 in 2021, then tumbled by 52.10% to $433,000 in 2022, then climbed by 5.25% to $441,000 in 2023, then reached $729,000 in 2025.
  • Its Short-term Investments was $729,000 in Q3 2025, compared to $441,000 in Q3 2023 and $530,000 in Q2 2023.